Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Cited by (1,000)

Items 901–1,000 of 1,000

1. Pharmacological Effects of Selected Medicinal Plants and Vitamins Against COVID-19
   Clément G. Yedjou · 2021
2. IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide
   Bruno J. de Andrade Silva, Paul A. Krogstad, Rosane M. B. Teles, Priscila R. Andrade, Jacob Rajfer, Monica G. Ferrini, Otto O. Yang, Barry R. Bloom, Robert L. Modlin · 2023 · Frontiers in Immunology
3. New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19
   Soo‐Jeung Park, Da‐Eun Nam, Hae Chang Seong, Young S. Hahn · 2022 · Frontiers in Immunology
4. COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
   Maristella Bungaro, Francesco Passiglia, Giorgio V. Scagliotti · 2022 · Biomedicines
5. NK cell dysfunction is linked with disease severity in SARS‐CoV‐2 patients
   Khadijeh Dizaji Asl, Zeinab Mazloumi, Ghazal Majidi, Hossein Kalarestaghi, Shahnaz Sabetkam, Ali Rafat · 2022 · Cell Biochemistry and Function
6. SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol)
   Sanjiv K. Hyoju, Olga Y. Zaborina, Harry van Goor · 2020 · Medical Hypotheses
7. Mechanisms of Infection By SARS-CoV-2, Inflammation and Potential Links With the Microbiome
   María Magdalena Aguirre‐García, Javier Mancilla-Galindo, Mercedes Paredes‐Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila‐Vanzzini · 2021 · Future Virology
8. NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection
   Marina Saresella, Daria Trabattoni, Ivana Marventano, Federica Piancone, Francesca La Rosa, Antonio Caronni, Agata Lax, Luca N. C. Bianchi, Paolo Innocente Banfi, Jorge Navarro et al. · 2021 · Molecular Neurobiology
9. T cell responses to SARS-CoV-2 in humans and animals
   Sameer-ul-Salam Mattoo, Jinjong Myoung · 2022 · The Journal of Microbiology
10. Decreased Serum Levels of Angiotensin Converting Enzyme (ACE)2 and Enhanced Cytokine Levels with Severity of COVID-19: Normalisation Upon Disease Recovery
    Esmaeil Mortaz, Hamidreza Jamaati, Neda Dalil Roofchayee, Hakime Sheikhzade, Maryam Sadat Mirenayat, Mohsen Sadeghi, Somayeh Lookzadeh, Neda K. Dezfuli, Gert Folkerts, Sharon E. Mumby et al. · 2021 · Heliyon
11. Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials
    Pooya Farhangnia, Shiva Dehrouyeh, Amir Reza Safdarian, Soheila Vasheghani Farahani, Melika Gorgani, Nima Rezaei, Mahzad Akbarpour, Ali‐Akbar Delbandi · 2022 · International Immunopharmacology
12. Rethinking sepsis after a two-year battle with COVID-19
    Yingying Zhang, Jiahuai Han · 2022 · Cellular and Molecular Immunology
13. Metformin use amid coronavirus disease 2019 pandemic
    Chia Siang Kow, Syed Shahzad Hasan · 2020 · Journal of Medical Virology
14. Modelling lockdown-induced 2 nd COVID waves in France
    Jean Daunizeau A, Rosalyn Moran, Jules Brochard, Jérémie Mattout, Richard S. J. Frackowiak, Karl John Friston · 2020 · medRxiv
15. Host-directed therapies: a potential solution to combat COVID-19
    Piyush Baindara, Sonali Agrawal, Santi M. Mandal · 2020 · Expert Opinion on Biological Therapy
16. Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors Against Main Protease of SARS-CoV-2
    R B Patel, Akash Vanzara, Nimisha Patel, Ajit M. Vasava, Sachin Prakash Patil, Kishore Shankarsinh Rajput · 2020 · ChemRxiv
17. COVID-19 – pathogenesis and immunological findings across the clinical manifestation spectrum
    Rita Carsetti, Isabella Quinti, Franco Locatelli · 2021 · Current Opinion in Pulmonary Medicine
18. The effect of Epstein–Barr virus viremia on the progression to severe COVID-19
    Jae Hyoung Im, Chung Hyun Nahm, Young Soo Je, Jin Soo Lee, Ji Hyeon Baek, Hea Yoon Kwon, Moon‐Hyun Chung, Ji-Hun Jang, Jung Soo Kim, Jun Hyeok Lim et al. · 2022 · Medicine
19. A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection
    Fadi Shehadeh, Gregorio Benitez, Evangelia K. Mylona, Quynh‐Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski, Eleftherios E Mylonakis · 2022 · The Journal of Infectious Diseases
20. Antioxidant and Immune-Related Implications of Minerals in COVID-19: A Possibility for Disease Prevention and Management
    Juan M. Toledano, María Puche-Juárez, Jorge Moreno‐Fernández, Julio José Ochoa, Javier Díaz‐Castro · 2023 · Antioxidants
21. Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
    Can Yue, Pengyan Wang, Jinmin Tian, George F. Gao, Kefang Liu, William J. Liu · 2023 · International Journal of Biological Sciences
22. Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review
    Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee · 2024 · Reviews in Medical Virology
23. Is innate immunity our best weapon for flattening the curve?
    Leonard Angka, Marisa Market, Michele Ardolino, Rebecca C. Auer · 2020 · Journal of Clinical Investigation
24. COVID-19 Infection: Concise Review Based on the Immunological Perspective
    Parisa Lotfinejad, Zahra Asadzadeh, Shiva Najjary, Mohammad Hossein Somi, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh, Afshin Derakhshani, Elmira Roshani, Behzad Baradaran · 2020 · Immunological Investigations
25. A 21st Century Evil: Immunopathology and New Therapies of COVID-19
    Taylon Felipe Silva, Fernanda Tomiotto‐Pellissier, Raquel Arruda Sanfelice, Manoela Daiele Gonçalves, Bruna Taciane da Silva Bortoleti, Mariana Barbosa Detoni, Ana Carolina Jacob Rodrigues, Amanda Cristina Machado Carloto, Virgínia Márcia Concato, Elaine da Silva Siqueira et al. · 2020 · Frontiers in Immunology
26. An overview of some potential immunotherapeutic options against COVID-19
    Maryam Bayat, Yahya Asemani, Mohammad Reza Mohammadi, Mahsa Sanaei, Mozhdeh Namvarpour, Reyhaneh Eftekhari · 2021 · International Immunopharmacology
27. Review of studies of severe acute respiratory syndrome related coronavirus–2 pathogenesis in human organoid models
    Ece Egilmezer, William D. Rawlinson · 2021 · Reviews in Medical Virology
28. Prolonged humoral and cellular immunity in COVID-19-recovered patients
    May A. Alsayb, Ali Dakhilallah D. Alsamiri, Hatem Q. Makhdoom, Turki Alwasaidi, Haitham Osman, Waleed H. Mahallawi · 2021 · Saudi Journal of Biological Sciences
29. Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
    Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig · 2021 · Life
30. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse
    Sarvin Sanaie, Elham Golipour, Ali Shamekh, Mohammad Reza Sadaie, Ata Mahmoodpoor, Mehdi Yousefi · 2021 · International Immunopharmacology
31. Neuropathy in COVID-19 associated with dysbiosis-related inflammation
    Büşra Aktaş, Belma Aslım · 2021 · TURKISH JOURNAL OF BIOLOGY
32. Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study
    Lennard P. L. Gilissen, Stefan G. H. Heinen, Lotte Rijpma-Jacobs, Erik J. Schoon, Ramon-Michel Schreuder, Annemarie M. J. Wensing, Mirjam C. M. van der Ende‐van Loon, Johanne G. Bloemen, Janneke M. Stapelbroek, Arnold Stronkhorst · 2021 · Clinical and Experimental Medicine
33. Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus-2 infection: a systematic review
    Jiacai Cho, Joanne Lee, Ching‐Hui Sia, Chieh Sian Koo, Benjamin YQ Tan, Wei-Zhen Hong, Ellie Ci-En Choi, Xueying Goh, Louis Yi Ann Chai, NishaSuyien Chandran et al. · 2021 · Singapore Medical Journal
34. Cancer and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization and Bioinformatic Analysis
    Yiyin Zhang, Qijiang Mao, Yirun Li, Jiaxi Cheng, Qiming Xia, Guoqiao Chen, Peng Chen, Shengxi Jin, Duguang Li, Cheng Zhong et al. · 2022 · Frontiers in Cell and Developmental Biology
35. Deciphering the Neurosensory Olfactory Pathway and Associated Neo-Immunometabolic Vulnerabilities Implicated in COVID-Associated Mucormycosis (CAM) and COVID-19 in a Diabetes Backdrop—A Novel Perspective
    Maryada Sharma, Hari Pankaj Vanam, Naresh Kumar Panda, Sourabha Kumar Patro, Rhythm Arora, Sanjay Kumar Bhadada, Shivaprakash Mandya Rudramurthy, Mini Pritam Singh, Purushotham Reddy Koppula · 2022 · Diabetology
36. Effect of hyperglycemia on the immune function of COVID-19 patients with type 2 diabetes mellitus: a retrospective study
    Ye Wang, Bo Yi, Shujun Wang, Xiaolin Chen, Zhongyuan Wen · 2022 · PeerJ
37. Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic
    Yuting Sun, Bin Luo, Yue-Ping Liu, Yu-Zhang Wu, Yong-Wen Chen · 2023 · Frontiers in Immunology
38. Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study
    Vanessa Costa Alves Galúcio, Daniel Carvalho de Menezes, Patrícia Danielle Lima de Lima, Vera Regina da Cunha Menezes Palácios, Pedro Fernando da Costa Vasconcelos, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão · 2023 · Viruses
39. Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome
    А. А. Савченко, Igor Vladimirovich Kudryavtsev, Dmitry Isakov, Ivan S. Sadowski, V. D. Belenyuk, А. Г. Борисов · 2023 · Pharmaceuticals
40. Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
    A. M. Das, Swarnali Khan, Syamal Roy, Shantanabha Das · 2023 · Exploration of Drug Science
41. Behavioral strategies to prevent and mitigate COVID-19 infection
    Noah T. Hutchinson, Andrew J. Steelman, Jeffrey A. Woods · 2020 · Sports Medicine and Health Science
42. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads
    Martijn Hoevenaar, Dolf Goossens, Janne Roorda · 2020 · Journal of the Renin-Angiotensin-Aldosterone System
43. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity
    Patricia Lamadrid, M. Alonso-Peña, David San Segundo, M. Arias-Loste, J. Crespo, M. López-Hoyos · 2021 · Frontiers in Immunology
44. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
    Irene García-García, Pilar Guerra‐García, Cristina Ferreras, Alberto Manuel Borobia, Antonio J. Carcas, Javier Queiruga‐Parada, J. L. Vicario, Isabel Mirones, Carlos Solano, Cristina Eguizábal et al. · 2021 · Trials
45. COVID-19 and Fungal Diseases
    Kyoung Ho Oh, Seung Hoon Lee · 2022 · Antibiotics
46. Inhibition of Viral Macrodomain of COVID-19 and Human TRPM2 by losartan
    Azhar Salari-Jazi, Karim Mahnam, Sayed Hossein Hejazi, Mohammad Sadegh Damavandi, Parisa Sadeghi, Mehrdad Zeinalian, Faezeh Tabesh, Seyedeh Mahnaz Mirbod, Hossein Khanahmad · 2020 · Preprints.org
47. Interplay of Monocytes and T Lymphocytes in COVID-19 Severity
    Lindsey E. Padgett, Huy Q. Dinh, Serena Chee, Claire E. Olingy, Runpei Wu, Daniel J. Araujo, Pandurangan Vijayanand, Christian H. H. Ottensmeier, Catherine C. Hedrick · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
48. Profound CD8 T cell responses towards the SARS-CoV-2 ORF1ab in COVID-19 patients
    Anastasia Gangaev, Steven L. C. Ketelaars, Sanne Patiwael, Anna Dopler, Olga I. Isaeva, Kelly Hoefakker, Sara De Biasi, Cristina Mussini, Giovanni Guaraldi, Massimo Girardis et al. · 2020
49. COVID-19 and Coronary Heart Disease
    Adiba Naz, Muntasir Billah · 2021 · Encyclopedia
50. A comprehensive assessment of four whole blood stabilizers for flow‐cytometric analysis of leukocyte populations
    Ngoc-anh A. Nguyen, Xiaobo Huang, Luz E. Cabrera, Pirkka T. Pekkarinen, Kirsten Nowlan, Tomas M. Strandin, Anu Kantele, Olli P. Vapalahti, Santtu Heinonen, Eliisa Kekäläinen · 2022 · Cytometry Part A
51. Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection
    Maren Claus, Naomi Pieris, Doris Urlaub, Peter Bröde, Bernhard Schaaf, Deniz Durak, Frank Renken, Carsten Watzl · 2023 · Frontiers in Cellular and Infection Microbiology
52. COVID-19: A threat to the respiratory system
    Ghulam Rasool, Waqas Ahmad Khan, Arif Khan, Muhammad Riaz, Mazhar Abbas, Aziz Ur Rehman, Saba Irshad, Saeed Ahmad · 2024 · International Journal of Immunopathology and Pharmacology
53. Convalescent donor SARS‐COV‐2‐specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID‐19 patients with severe disease has not received enough attention till date
    Brian P. Hanley, Candice A. Roufosse, Michael Osborn, Kikkeri N. Naresh · 2020 · British Journal of Haematology
54. Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine
    Andualem Henok, Mulugeta Kiros, Sisay Getu, Wasihun Hailemichael · 2020 · ImmunoTargets and Therapy
55. Herpes Zoster May Be a Marker for COVID-19 Infection During Pregnancy
    Mohamed Lotfy Elsaie, Eman A. Youssef, Hesham Nada · 2021 · Cutis
56. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
    Yeon-Woo Kang, Subin Park, Kun-Joo Lee, D. Moon, Young-Min Kim, Seung-Woo Lee · 2021 · Immune Network
57. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?
    Rita Lauro, Natasha Irrera, Ali Hussein Eid, Alessandra Bitto · 2021 · Pathogens
58. An immunogenetic view of COVID-19
    Vitor R. C. Aguiar, Danillo G. Augusto, Erick C. Castelli, Jill A. Hollenbach, Diogo Meyer, Kelly Nunes, Maria Luiza Petzl‐Erler · 2021 · Genetics and Molecular Biology
59. Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches
    Hany E. S. Marei, Asmaa A. Al Thani, Nahla M. Afifi, Giacomo Pozzoli, Thomas Caceci, Franco Angelini, Carlo Cenciarelli · 2021 · Molecular Biology Reports
60. Asymptomatic COVID-19 Individuals Tend to Establish Relatively Balanced Innate and Adaptive Immune Responses
    Miao Li, Yue Zhang, Jianhua Lu, Li Li, Huixia Gao, Cuiqing Ma, Erhei Dai, Lin Wei · 2021 · Pathogens
61. Transcriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA
    Dongyao Wang, Dong Wang, Min Huang, Xiaohu Zheng, Yiqing Shen, Binqing Fu, Hong Zhao, Xianxiang Chen, Peng Peng, Qi Zhu et al. · 2021 · Journal of Molecular Cell Biology
62. Potential of germanium-based compounds in coronavirus infection
    Віолетта Петрівна Нароха, Iryna Nizhenkovska, Олена Кузнецова · 2021 · Acta Pharmaceutica
63. SARS-CoV-2 and HIV co-infection; clinical features, diagnosis, and treatment strategies: A systematic review and meta-analysis
    Masoud Dadashi, Ali Dadashi, Fatemeh Sameni, Shahram Sayadi, Mehdi Goudarzi, Mohammad Javad Nasiri, Somayeh Yaslianifard, Mona Ghazi, Reza Arjmand, Bahareh Hajikhani · 2022 · Gene Reports
64. An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19
    Saeede Soleimanian, Soheila Sadat Alyasin, Najmeh Sepahi, Zahra Ghahramani, Zahra Kanannejad, Ramin Yaghobi, Mohammad Hossein Karimi · 2022 · Frontiers in Immunology
65. Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key
    Kriti Khare, Rajesh Pandey · 2022 · Frontiers in Immunology
66. The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule
    Jéssica Fernanda Corrêa Cordeiro, Talita Morais Fernandes, Diana Mota Toro, Pedro Vieira Da Silva-Neto, Vinícius E. Pimentel, Malena M. Pérez, Jonatan C. S. de Carvalho, Thais Fernanda de Campos Fraga‐Silva, Camilla N. S. Oliveira, Jamille Guedes Malta Argolo et al. · 2022 · International Journal of Molecular Sciences
67. Genetic predisposition to blood cell indices in relation to severe COVID‐19
    Yao Yao, Hongfei Song, Fanshuang Zhang, Ji‐Bin Liu, Dong Wang, Quansheng Feng, Shuquan Rao, Cen Jiang · 2022 · Journal of Medical Virology
68. SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level
    Catherine D. Demoliou, Christos P. Papaneophytou, Vicky Nicolaidou · 2022 · International Journal of Medical Sciences
69. Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs
    Ranjeet Maurya, Uzma Shamim, Pallavi Mishra, Aparna Swaminathan, Aakarshan Raina, Bansidhar Tarai, Sandeep Budhiraja, Rajesh Pandey · 2023 · Microbiology Spectrum
70. Effect of Cytomegalovirus Reactivation on Inflammatory Status and Mortality of Older COVID-19 Patients
    Robertina Giacconi, Maurizio Cardelli, Francesco Piacenza, Elisa Pierpaoli, Elisabetta Farnocchia, Mirko Di Rosa, Anna Rita Bonfigli, Tiziana Casoli, Francesca Marchegiani, Fiorella Marcheselli et al. · 2023 · International Journal of Molecular Sciences
71. A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
    Jason A. Hackney, Haridha Shivram, Jason A. Vander Heiden, Christopher C. Overall, Luz D. Orozco, Xia Gao, Eugene S. Kim, Nathaniel R. West, Aditi Qamra, Diana Chang et al. · 2023 · iScience
72. Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
    Pureum Lee, Doo-Jin Kim · 2020 · Immune Network
73. Investigation of immune cells on elimination of pulmonary‐Infected COVID‐19 and important role of innate immunity, phagocytes
    Esmaeil Farshi, Bahram Kasmapur, Anya Arad · 2020 · Reviews in Medical Virology
74. SARS-CoV-2 Pandemic Impacts on NASA Ground Operations to Protect ISS Astronauts
    George Makedonas, Satish Kumar Mehta, Richard A. Scheuring, Robert Haddon, Brian E. Crucian · 2020 · The Journal of Allergy and Clinical Immunology In Practice
75. Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report
    Salvatore Corrao, Francesco Gervasi, Francesca Di Bernardo, Giuseppe Natoli, Massimo Raspanti, Nicola Catalano, Christiano Argano · 2021 · Journal of Clinical Medicine
76. Prognostic factors for predicting severity and mortality in hospitalized COVID‐19 patients
    Fahad Dakilallah Aljohani, Amin Khattab, Hossein Mostafa Elbadawy, Aisha Alhaddad, Ziab Zakey Alahmadey, Yaser Masuod Alahmadi, Heba Mahmoud Eltahir, Heba M. H. Matar, Hanaa Wanas · 2022 · Journal of Clinical Laboratory Analysis
77. COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity
    Susana David, Guillermo Dorado, Elsa Leclerc Duarte, Stéphanie David-Bosne, João M. Trigueiro-Louro, Helena Rebelo‐de‐Andrade · 2022 · Immunogenetics
78. Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients
    Liqin Yao, Lingeng Lu, Wenxue Ma · 2022 · Heliyon
79. Correlation of the Imbalance in the Circulating Lymphocyte Subsets With C-Reactive Protein and Cardio-Metabolic Conditions in Patients With COVID-19
    Anton Victorovich Tyurin, Milyausha K. Salimgareeva, Ildar R. Minniakhmetov, Rita Igorevna Khusainova, Alexandr Samorodov, В. Н. Павлов, Julia G. Kzhyshkowska · 2022 · Frontiers in Immunology
80. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like sequence
    Vincent Navratil, Loïc Lionnard, Sonia Longhi, J. Marie Hardwick, Christophe Combet, Abdel Aouacheria · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
81. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
    Aljawharah Alrubayyi, Ester Gea‐Mallorquí, Emma Touizer, Dan Hameiri‐Bowen, Jakub T. Kopycinski, Bethany G. Charlton, Natasha Fisher-Pearson, Luke Muir, Annachiara Rosa, Chloë Roustan et al. · 2021 · Research Square
82. Deep spatial profiling of COVID19 brains reveals neuroinflammation by compartmentalized local immune cell interactions and targets for intervention
    Bertram Bengsch, Marius Schwabenland, Henrike Salié, Jovan Tanevski, Saskia Killmer, Jakob Matschke, Klaus Püschel, Henrik E. Mei, Tobias Boettler, Christoph Neumann‐Haefelin et al. · 2020 · Research Square
83. Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
    Rupsha Fraser, Aurelio Orta Resendiz, David Harold Dockrell, Michaela C. Müller-Trutwin, Alexander Mazein · 2023 · European Respiratory Review
84. Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics
    Han Sun, Dan Huang, Huiling Zhang, Min Dong, Simiao Wang, Man Sun, Jiayi Liu, Yiqi Wang, Xiaojie Qu, Xuefeng Li et al. · 2025 · MedComm – Oncology
85. Reversing immunosenescence for prevention of COVID-19
    Robert T. Brooke, Gregory M. Fahy · 2020 · Aging
86. COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making
    Christopher Larson, Bryan T. Oronsky, Sharad Goyal, Carolyn M. Ray, Farah Hedjran, Terese Hammond, Santosh Kesari, Scott Z. Caroen, Michelle Lybeck, Vaughn E. Dobalian et al. · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
87. Vacinas contra a Covid-19: estado da arte
    Xênia Macedo Souto · 2020 · Recital - Revista de Educação Ciência e Tecnologia de Almenara/MG
88. Pathomorphological and immunohistochemical features of lymph nodes in COVID-19 patients (autopsy study)
    Alla Mikhailovna Kovrigina, Elena A. Shalamova, Yu. S. Berezovskiy, Dmitry Valerievich Kalinin, Evgeniy Gretsov, T. R. Bаgdаsаryan, Lyudmila A. Semenova, Dmitry I. Chebоtarev, Maria V. Samsonova, Andrey L. Chernyaev et al. · 2020 · CLINICAL AND EXPERIMENTAL MORPHOLOGY
89. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID‐19 Patients
    Nan Jiang, Zhijun Li, Bo Yang, Mengdi Jin, Yaoyao Sun, Yang He, Yang Liu, Yueying Wang, Daoyuan Si, Piyong Ma et al. · 2021 · BioMed Research International
90. COVID-19 and pregnancy: are they friends or enemies?
    Tamara Gulić, Gordana Blagojević Zagorac · 2021 · Hormone Molecular Biology and Clinical Investigation
91. CSGBBNet: An Explainable Deep Learning Framework for COVID-19 Detection
    Xujing Yao, Ziquan Zhu, Shuihua Wang, Yudong Zhang · 2021 · Diagnostics
92. Screening of potential inhibitors of COVID-19 with repurposing approach via molecular docking
    Negin Alizadehmohajer, Abtin Behmardi, Simin Najafgholian, Shabnam Moradi, Forogh Mohammadi, Reza Nedaeinia, Shaghayegh Haghjooy Javanmard, Ehsan Sohrabi, Rasoul Salehi, Gordon A. Ferns et al. · 2022 · Network Modeling Analysis in Health Informatics and Bioinformatics
93. Combined plasma levels of IL‐10 and testosterone, but not soluble HLA‐G5, predict the risk of death in COVID‐19 patients
    Giada Amodio, Paolo Capogrosso, Marina Pontillo, Michela Giulia Tassara, Luca Boeri, Cristina Carenzi, Daniele Cignoli, Anna Maria Ferrara, Giuseppe Alvise Ramirez, Cristina Tresoldi et al. · 2022 · Andrology
94. Effects of Echinacea purpurea supplementation on markers of immunity, health, intake, and growth of dairy calves
    Brooklynn McNeil, David L. Renaud, M.A. Steele, A.J. Keunen, T.J. DeVries · 2023 · Journal of Dairy Science
95. Exploring the causes of mild COVID-19 involvement in pediatric patients
    Alvand Naserghandi, R. Saffarpour, Seyed Farshad Allameh · 2020 · New Microbes and New Infections
96. COVID-19 in a Patient with Advanced Merkel Cell Carcinoma Receiving Immunotherapy
    Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, Artur Katz, Rodrigo Ramella Munhoz · 2020 · Immunotherapy
97. Features of HLA class I expression and its clinical relevance in SARS‐CoV‐2: What do we know so far?
    Abdellatif Bouayad · 2021 · Reviews in Medical Virology
98. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients
    Sana Shabbir, Muhammad Hassan Raza, Muhammad Arshad, Muhammad Jawad Khan · 2021 · Archives of Virology
99. Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
    Elena Lo Presti, Francesco Dieli, Serena Meraviglia · 2021 · Vaccines
100. Range of Varicella Zoster Co-Infections with COVID-19, Singapore
     Jerold Loh, Sai Meng Tham, Paul Anantharajah Tambyah, Gabriel Zherong Yan, Chun Kiat Lee, Louis Yi Ann Chai · 2021 · Infection and Chemotherapy